• Fibrinogen (Functional)
  • Oncology Pharmacogenetics (PGx) Gene Variation Panel
  • C-Reactive Protein, High Sensitivity (hsCRP)
  • FoundationOne®CDx (F1CDx) and FoundationOne® Liquid CDx
  • Cancer Antigen (CA) 19-9, Serum
  • Coagulation Factor VIII Activity Assay, Plasma
  • Colon Cancer Multi-Gene Panel, NGS (ColoNext®, COLONSEQ, COLONSEQPlus)
  • Bilirubin Total, Serum
  • Platelet Function Analysis
  • Multi Gene Methylation Assay for Hepatocellular Carcinoma by NGS (HelioLiver™, HelioHCC™ Trace, EarlyDx MethylScan™)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /The BT-Reveal Early Pancreatic Cancer Test
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

The BT-Reveal Early Pancreatic Cancer Test
Medical Test

Reference Ranges
Access to The BT-Reveal Early Pancreatic Cancer Test is restricted.
Loading...